Preimplantation Genetic Testing for Aneuploidy
PGT-P, preimplantation genetic testing for polygenic disorders, is for couples wanting more information about the chance their children will have an increased risk for specific polygenic conditions. Polygenic disorders are diseases influenced by genetic variants in more than one gene.
The combination of variants in these several genes affects the likelihood of developing polygenic conditions over the course of an individual's lifetime. Genomic Prediction is proud to be the first company to offer this option to families. Couples have the ability to choose which polygenic conditions they want included in their screening from the list below.
A number of polygenic conditions are available for screening including:
⦿ Type 1 and Type 2 Diabetes Schizophrenia
⦿ Certain cancers such as Breast Cancer, Testicular Cancer
⦿ Prostate Cancer, Malignant Melanoma and Basal Cell Carcinoma
⦿ Coronary Artery Disease, Hypercholesterolemia, Hypertension and Heart Attack Risk
You have the option to test for one, some or all of the conditions included on the panel.
The genetic counselor will review the benefits and limitations of PGT-P testing. Parental saliva samples are collected (if possible) to aid the testing process.
Embryos are produced through an IVF cycle.
The clinic carefully takes a small sample from each embryo. A small number of cells from the embryo are sent to Genomic Prediction Clinical Laboratory for analysis. Embryos are not shipped to our laboratory, we only need to examine the biopsy samples.
The team at Genomic Prediction Clinical Laboratory carefully analyzes the genetic material present within each embryo biopsy sample.